(Q36872926)

16 August 2017

1 reference

title

International perspectives, progress, and future challenges of paediatric HIV infection (English)

1 reference

16 August 2017

5

Philip Goulder

1 reference

16 August 2017

1

Andrew Prendergast

1 reference

16 August 2017

Gareth Tudor-Williams

series ordinal

2

1 reference

16 August 2017

Prakash Jeena

series ordinal

3

1 reference

16 August 2017

Sandra Burchett

series ordinal

4

1 reference

16 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

16 August 2017

1 reference

16 August 2017

370

1 reference

16 August 2017

9581

1 reference

16 August 2017

68-80

1 reference

Five year follow up of vertically HIV infected children in a randomised double blind controlled trial of immediate versus deferred zidovudine: the PENTA 1 trial

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

18-Month mortality and perinatal exposure to zidovudine in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Predictors of early mortality in a cohort of human immunodeficiency virus type 1-infected african children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Monitoring the scale-up of antiretroviral therapy programmes: methods to estimate coverage.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Children and HIV in Africa: what is next?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Evidence behind the WHO guidelines: hospital care for children: what antiretroviral agents and regimens are effective in the prevention of mother-to-child transmission of HIV?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Strategies to prevent mother-to-child transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Current issues in the prevention of mother-to-child transmission of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Late postnatal transmission of HIV-1 and associated factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Balancing maternal and infant benefits and the consequences of breast-feeding in the developing world during the era of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Breast-feeding and HIV-1 transmission: how risky for how long?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Sexual abuse of children: intersection with the HIV epidemic

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Transmission of HIV-1 infection in sub-Saharan Africa and effect of elimination of unsafe injections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Risk factors for mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A prospective population-based study of HIV perinatal transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Prospective comparison of mother-to-child transmission of HIV-1 and HIV-2 in Abidjan, Ivory Coast

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Mother-to-child transmission of human immunodeficiency virus type 1: report from the Nairobi Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Risk factors for mother-to-child transmission of human immunodeficiency virus-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Timing of human immunodeficiency virus type 1 (HIV-1) transmission from mother to child: bayesian estimation using a mixture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A review of clinical trials to prevent mother-to-child HIV-1 transmission in Africa and inform rational intervention strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Longitudinal study of 94 symptomatic infants with perinatally acquired human immunodeficiency virus infection. Evidence for a bimodal expression of clinical and biological symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Maternal viral load and rate of disease progression among vertically HIV-1-infected children: an international meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Pneumocystis carinii pneumonia and cytomegalovirus infection in children with vertically acquired HIV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Mother-to-Child HIV-1 Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Child mortality and HIV infection in Africa: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

The devastating effects of HIV/AIDS on children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Extended family caring for children orphaned by AIDS: balancing essential work and caregiving in a high HIV prevalence nations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

HIV infection among paediatric in-patients in Blantyre, Malawi.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Pneumocystis carinii and cytomegalovirus infections in severely ill, HIV-infected African infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Disease in children infected with HIV in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Pneumocystis cariniiPneumonia: An Uncommon Cause of Death in African Patients with Acquired Immunodeficiency Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Pneumocystis carinii pneumonia in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A prospective study of diarrhea and HIV-1 infection among 429 Zairian infants

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Diagnosed tuberculosis during the follow-up of a cohort of human immunodeficiency virus-infected children in Abidjan, Côte d'Ivoire: ANRS 1278 study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Effects of the human immunodeficiency virus on tuberculosis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

The effect of Plasmodium falciparum malaria on HIV-1 RNA blood plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Immune activation is a dominant factor in the pathogenesis of African AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

HIV and SIV CTL escape: implications for vaccine design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Early therapy of vertical human immunodeficiency virus type 1 (HIV-1) infection: control of viral replication and absence of persistent HIV-1-specific immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

HIV evolution: CTL escape mutation and reversion after transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A longitudinal assessment of autologous neutralizing antibodies in children perinatally infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Antibody neutralization and escape by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Early Progression of Disease in HIV-Infected Infants with Thymus Dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Maternal versus paternal inheritance of HLA class I alleles among HIV-infected children: consequences for clinical disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Unique acquisition of cytotoxic T-lymphocyte escape mutants in infant human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

CD4 Percentages and Total Lymphocyte Counts as Early Surrogate Markers for Pediatric HIV-1 Infection in Resource-Limited Settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Evaluation and simplification of the World Health Organization clinical case definition for paediatric AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Guidelines for the management of HIV infection in pregnant women and the prevention of mother-to-child transmission of HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Antiretroviral treatment in resource-poor settings: clinical research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A microchip CD4 counting method for HIV monitoring in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

The role of non-viral load surrogate markers in HIV-positive patient monitoring during antiviral treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Use of total lymphocyte count for monitoring response to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A new model to monitor the virological efficacy of antiretroviral treatment in resource-poor countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Growth failure as a prognostic indicator of mortality in pediatric HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Viral load and CD4+ T lymphocyte response to highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children: an observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Changes in the human thymus during aging

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Immunological recovery despite virological failure is independent of human immunodeficiency virus-type 1 resistant mutants in children receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

PENTA guidelines for the use of antiretroviral therapy, 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Gastrostomy tube insertion for improvement of adherence to highly active antiretroviral therapy in pediatric patients with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Lactic acidemia in human immunodeficiency virus-uninfected infants exposed to perinatal antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Highly active antiretroviral-treated HIV-infected children show fat distribution changes even in absence of lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Metabolic abnormalities in HIV type 1-infected children treated and not treated with protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Effects of highly active antiretroviral therapy on paediatric metabolite levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Treatment outcomes stratified by baseline immunological status among young children receiving nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Addressing the paediatric HIV epidemic: a perspective from the Western Cape Region of South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Highly active antiretroviral therapies among HIV-1-infected children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Outcomes of HIV-infected orphaned and non-orphaned children on antiretroviral therapy in western Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Estimating the number of vertically HIV-infected children eligible for antiretroviral treatment in resource-limited settings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

A family clinic--optimising care for HIV infected children and their families.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

Disclosure of HIV/AIDS diagnosis to HIV-infected children in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961051-4

7 January 2021

10.1016/S0140-6736(07)61051-4

Identifiers

DOI

1 reference

16 August 2017

1 reference